Shambhavi Naik believes gene editing in children should remain unregulated beyond ensuring safety and compliance with existing laws. But what does "safe" mean? Where do we draw the line between therapy and enhancement? And what if someone goes rogue?
Shambhavi is the Head of Research at Takshashila and chairs its Advanced Biology programme. A PhD in Cancer Biology, she has contributed to WHO guidelines on gene editing, India’s risk assessment of genetically modified crops, and the Rajya Sabha Parliamentary Committee’s work on the DNA Profiling Bill.
Episode notes: https://deepakvs.com/podcast
